AMDL Inc a US-based pharmaceutical company with major operations in China, announced today the launch of a new brand name for its DR-70 (FDP) in vitro diagnostic cancer test. With today’s announcement, AMDL will manufacture, market, and sell DR-70 under the brand name Onko-Sure.
Read More
LabCorp Enters Definitive Agreement to Acquire Monogram Biosciences Laboratory Corp of America® Holdings (LabCorp) and Monogram Biosciences Inc announced recently that they have entered into a definitive agreement and plan of merger under which
Read More
Pharmacogenetics has the potential to avoid some of the three quarter million adverse drug events seen each year.
Read MoreExosome Diagnostics Inc and DxS Ltd today announced that they will collaborate on the development of blood based companion diagnostics for key cancer gene mutations, such as KRAS, BRAF and EGFR.
Read MoreSCC Soft Computer announces that their SoftPath synoptic reporting tool has been certified by Cancer Care Ontario.
Read More